Skip to main content
Erschienen in: Abdominal Radiology 8/2018

19.09.2017 | Invited article

Venous invasion by hepatic tumors: imaging appearance and implications for management

verfasst von: Scott M. Thompson, Michael L. Wells, James C. Andrews, Eric C. Ehman, Christine O. Menias, Christopher L. Hallemeier, Lewis R. Roberts, Sudhakar K. Venkatesh

Erschienen in: Abdominal Radiology | Ausgabe 8/2018

Einloggen, um Zugang zu erhalten

Abstract

Venous invasion by hepatic tumors most commonly occurs with hepatocellular carcinoma and is associated with worse patient prognosis. Imaging plays an important role in the diagnosis of tumor thrombus in the liver. Moreover, differentiating between bland and tumor thrombus in the liver has important diagnostic, staging, therapeutic, and prognostic implications and may require a multimodal imaging approach including ultrasound, computed tomography, and/or magnetic resonance imaging. Treatment of hepatic malignancies with associated tumor thrombus is dependent on tumor type, disease extent within the liver, liver hemodynamics, and underlying liver function. Treatment of such tumors may involve surgical, locoregional and/or systemic therapies. The current review will focus on the imaging characteristics of venous invasion by hepatic tumors. The imaging findings most useful for differentiating hepatic venous tumor thrombus and bland thrombus will be highlighted and demonstrated with imaging examples. Imaging findings with implications for subsequent patient management will be described.
Literatur
1.
Zurück zum Zitat Chan SL, Chong CC, Chan AW, Poon DM, Chok KS (2016) Management of hepatocellular carcinoma with portal vein tumor thrombosis: review and update at 2016. World J Gastroenterol 22(32):7289–7300CrossRefPubMedPubMedCentral Chan SL, Chong CC, Chan AW, Poon DM, Chok KS (2016) Management of hepatocellular carcinoma with portal vein tumor thrombosis: review and update at 2016. World J Gastroenterol 22(32):7289–7300CrossRefPubMedPubMedCentral
2.
Zurück zum Zitat Quirk M, Kim YH, Saab S, Lee EW (2015) Management of hepatocellular carcinoma with portal vein thrombosis. World J Gastroenterol 21(12):3462–3471CrossRefPubMedPubMedCentral Quirk M, Kim YH, Saab S, Lee EW (2015) Management of hepatocellular carcinoma with portal vein thrombosis. World J Gastroenterol 21(12):3462–3471CrossRefPubMedPubMedCentral
3.
Zurück zum Zitat Pirisi M, Avellini C, Fabris C, et al. (1998) Portal vein thrombosis in hepatocellular carcinoma: age and sex distribution in an autopsy study. J Cancer Res Clin Oncol 124(7):397–400CrossRefPubMed Pirisi M, Avellini C, Fabris C, et al. (1998) Portal vein thrombosis in hepatocellular carcinoma: age and sex distribution in an autopsy study. J Cancer Res Clin Oncol 124(7):397–400CrossRefPubMed
4.
Zurück zum Zitat Llovet JM, Bustamante J, Castells A, et al. (1999) Natural history of untreated nonsurgical hepatocellular carcinoma: rationale for the design and evaluation of therapeutic trials. Hepatology 29(1):62–67CrossRefPubMed Llovet JM, Bustamante J, Castells A, et al. (1999) Natural history of untreated nonsurgical hepatocellular carcinoma: rationale for the design and evaluation of therapeutic trials. Hepatology 29(1):62–67CrossRefPubMed
5.
Zurück zum Zitat Calvet X, Bruix J, Gines P, et al. (1990) Prognostic factors of hepatocellular carcinoma in the west: a multivariate analysis in 206 patients. Hepatology 12(4 Pt 1):753–760CrossRefPubMed Calvet X, Bruix J, Gines P, et al. (1990) Prognostic factors of hepatocellular carcinoma in the west: a multivariate analysis in 206 patients. Hepatology 12(4 Pt 1):753–760CrossRefPubMed
6.
Zurück zum Zitat Stuart KE, Anand AJ, Jenkins RL (1996) Hepatocellular carcinoma in the United States. Prognostic features, treatment outcome, and survival. Cancer 77(11):2217–2222CrossRefPubMed Stuart KE, Anand AJ, Jenkins RL (1996) Hepatocellular carcinoma in the United States. Prognostic features, treatment outcome, and survival. Cancer 77(11):2217–2222CrossRefPubMed
7.
Zurück zum Zitat Sereni CP, Rodgers SK, Kirby CL, Goykhman I (2017) Portal vein thrombus and infiltrative HCC: a pictoral review. Abdom Radiol (NY) 42(1):159–170CrossRef Sereni CP, Rodgers SK, Kirby CL, Goykhman I (2017) Portal vein thrombus and infiltrative HCC: a pictoral review. Abdom Radiol (NY) 42(1):159–170CrossRef
8.
Zurück zum Zitat Ganne-Carrie N, Layese R, Bourcier V, et al. (2016) Nomogram for individualized prediction of hepatocellular carcinoma occurrence in hepatitis C virus cirrhosis (ANRS CO12 CirVir). Hepatology 64(4):1136–1147CrossRefPubMed Ganne-Carrie N, Layese R, Bourcier V, et al. (2016) Nomogram for individualized prediction of hepatocellular carcinoma occurrence in hepatitis C virus cirrhosis (ANRS CO12 CirVir). Hepatology 64(4):1136–1147CrossRefPubMed
9.
Zurück zum Zitat Lewin M, Gelu-Simeon M, Ostos M, et al. (2015) Imaging features and prognosis of hepatocellular carcinoma in patients with cirrhosis who are coinfected with human immunodeficiency virus and hepatitis C virus. Radiology 277(2):443–453CrossRefPubMed Lewin M, Gelu-Simeon M, Ostos M, et al. (2015) Imaging features and prognosis of hepatocellular carcinoma in patients with cirrhosis who are coinfected with human immunodeficiency virus and hepatitis C virus. Radiology 277(2):443–453CrossRefPubMed
10.
Zurück zum Zitat Akin O, Dixit D, Schwartz L (2011) Bland and tumor thrombi in abdominal malignancies: magnetic resonance imaging assessment in a large oncologic patient population. Abdom Imaging 36(1):62–68CrossRefPubMed Akin O, Dixit D, Schwartz L (2011) Bland and tumor thrombi in abdominal malignancies: magnetic resonance imaging assessment in a large oncologic patient population. Abdom Imaging 36(1):62–68CrossRefPubMed
11.
Zurück zum Zitat Yamato H, Kawakami H, Kuwatani M, et al. (2009) Pancreatic carcinoma associated with portal vein tumor thrombus: three case reports. Intern Med 48(3):143–150CrossRefPubMed Yamato H, Kawakami H, Kuwatani M, et al. (2009) Pancreatic carcinoma associated with portal vein tumor thrombus: three case reports. Intern Med 48(3):143–150CrossRefPubMed
12.
Zurück zum Zitat Margini C, Berzigotti A (2017) Portal vein thrombosis: the role of imaging in the clinical setting. Dig Liver Dis 49(2):113–120CrossRefPubMed Margini C, Berzigotti A (2017) Portal vein thrombosis: the role of imaging in the clinical setting. Dig Liver Dis 49(2):113–120CrossRefPubMed
13.
Zurück zum Zitat Forner A, Gilabert M, Bruix J, Raoul JL (2014) Treatment of intermediate-stage hepatocellular carcinoma. Nat Rev Clin Oncol 11(9):525–535CrossRefPubMed Forner A, Gilabert M, Bruix J, Raoul JL (2014) Treatment of intermediate-stage hepatocellular carcinoma. Nat Rev Clin Oncol 11(9):525–535CrossRefPubMed
14.
Zurück zum Zitat Berzigotti A, Garcia-Criado A, Darnell A, Garcia-Pagan JC (2014) Imaging in clinical decision-making for portal vein thrombosis. Nat Rev Gastroenterol Hepatol 11(5):308–316CrossRefPubMed Berzigotti A, Garcia-Criado A, Darnell A, Garcia-Pagan JC (2014) Imaging in clinical decision-making for portal vein thrombosis. Nat Rev Gastroenterol Hepatol 11(5):308–316CrossRefPubMed
15.
Zurück zum Zitat Dodd GD 3rd, Memel DS, Baron RL, Eichner L, Santiguida LA (1995) Portal vein thrombosis in patients with cirrhosis: does sonographic detection of intrathrombus flow allow differentiation of benign and malignant thrombus? AJR Am J Roentgenol 165(3):573–577CrossRefPubMed Dodd GD 3rd, Memel DS, Baron RL, Eichner L, Santiguida LA (1995) Portal vein thrombosis in patients with cirrhosis: does sonographic detection of intrathrombus flow allow differentiation of benign and malignant thrombus? AJR Am J Roentgenol 165(3):573–577CrossRefPubMed
16.
Zurück zum Zitat Catalano OA, Choy G, Zhu A, Hahn PF, Sahani DV (2010) Differentiation of malignant thrombus from bland thrombus of the portal vein in patients with hepatocellular carcinoma: application of diffusion-weighted MR imaging. Radiology 254(1):154–162CrossRefPubMed Catalano OA, Choy G, Zhu A, Hahn PF, Sahani DV (2010) Differentiation of malignant thrombus from bland thrombus of the portal vein in patients with hepatocellular carcinoma: application of diffusion-weighted MR imaging. Radiology 254(1):154–162CrossRefPubMed
17.
Zurück zum Zitat Li C, Hu J, Zhou D, et al. (2014) Differentiation of bland from neoplastic thrombus of the portal vein in patients with hepatocellular carcinoma: application of susceptibility-weighted MR imaging. BMC Cancer 14:590CrossRefPubMedPubMedCentral Li C, Hu J, Zhou D, et al. (2014) Differentiation of bland from neoplastic thrombus of the portal vein in patients with hepatocellular carcinoma: application of susceptibility-weighted MR imaging. BMC Cancer 14:590CrossRefPubMedPubMedCentral
18.
Zurück zum Zitat Hu S, Zhang J, Cheng C, et al. (2014) The role of 18F-FDG PET/CT in differentiating malignant from benign portal vein thrombosis. Abdom Imaging 39(6):1221–1227CrossRefPubMed Hu S, Zhang J, Cheng C, et al. (2014) The role of 18F-FDG PET/CT in differentiating malignant from benign portal vein thrombosis. Abdom Imaging 39(6):1221–1227CrossRefPubMed
19.
Zurück zum Zitat Colagrande S, Centi N, La Villa G, Villari N (2004) Transient hepatic attenuation differences. AJR Am J Roentgenol 183(2):459–464CrossRefPubMed Colagrande S, Centi N, La Villa G, Villari N (2004) Transient hepatic attenuation differences. AJR Am J Roentgenol 183(2):459–464CrossRefPubMed
20.
Zurück zum Zitat Colagrande S, Centi N, Galdiero R, Ragozzino A (2007) Transient hepatic intensity differences: part 1, those associated with focal lesions. AJR Am J Roentgenol 188(1):154–159CrossRefPubMed Colagrande S, Centi N, Galdiero R, Ragozzino A (2007) Transient hepatic intensity differences: part 1, those associated with focal lesions. AJR Am J Roentgenol 188(1):154–159CrossRefPubMed
21.
Zurück zum Zitat Colagrande S, Centi N, Galdiero R, Ragozzino A (2007) Transient hepatic intensity differences: part 2, those not associated with focal lesions. AJR Am J Roentgenol 188(1):160–166CrossRefPubMed Colagrande S, Centi N, Galdiero R, Ragozzino A (2007) Transient hepatic intensity differences: part 2, those not associated with focal lesions. AJR Am J Roentgenol 188(1):160–166CrossRefPubMed
22.
Zurück zum Zitat Sharma AM, Zhu D, Henry Z (2016) Portal vein thrombosis: when to treat and how? Vasc Med 21(1):61–69CrossRefPubMed Sharma AM, Zhu D, Henry Z (2016) Portal vein thrombosis: when to treat and how? Vasc Med 21(1):61–69CrossRefPubMed
23.
Zurück zum Zitat Rossi S, Rosa L, Ravetta V, et al. (2006) Contrast-enhanced versus conventional and color Doppler sonography for the detection of thrombosis of the portal and hepatic venous systems. AJR Am J Roentgenol 186(3):763–773CrossRefPubMed Rossi S, Rosa L, Ravetta V, et al. (2006) Contrast-enhanced versus conventional and color Doppler sonography for the detection of thrombosis of the portal and hepatic venous systems. AJR Am J Roentgenol 186(3):763–773CrossRefPubMed
24.
Zurück zum Zitat Tarantino L, Francica G, Sordelli I, et al. (2006) Diagnosis of benign and malignant portal vein thrombosis in cirrhotic patients with hepatocellular carcinoma: color Doppler US, contrast-enhanced US, and fine-needle biopsy. Abdom Imaging 31(5):537–544CrossRefPubMed Tarantino L, Francica G, Sordelli I, et al. (2006) Diagnosis of benign and malignant portal vein thrombosis in cirrhotic patients with hepatocellular carcinoma: color Doppler US, contrast-enhanced US, and fine-needle biopsy. Abdom Imaging 31(5):537–544CrossRefPubMed
25.
Zurück zum Zitat Tarantino L, Ambrosino P, Di Minno MN (2015) Contrast-enhanced ultrasound in differentiating malignant from benign portal vein thrombosis in hepatocellular carcinoma. World J Gastroenterol 21(32):9457–9460CrossRefPubMedPubMedCentral Tarantino L, Ambrosino P, Di Minno MN (2015) Contrast-enhanced ultrasound in differentiating malignant from benign portal vein thrombosis in hepatocellular carcinoma. World J Gastroenterol 21(32):9457–9460CrossRefPubMedPubMedCentral
26.
Zurück zum Zitat Canellas R, Mehrkhani F, Patino M, Kambadakone A, Sahani D (2016) Characterization of portal vein thrombosis (neoplastic versus bland) on CT images using software-based texture analysis and thrombus density (hounsfield units). AJR Am J Roentgenol 207(5):W81–W87CrossRefPubMed Canellas R, Mehrkhani F, Patino M, Kambadakone A, Sahani D (2016) Characterization of portal vein thrombosis (neoplastic versus bland) on CT images using software-based texture analysis and thrombus density (hounsfield units). AJR Am J Roentgenol 207(5):W81–W87CrossRefPubMed
27.
Zurück zum Zitat Ascenti G, Sofia C, Mazziotti S, et al. (2016) Dual-energy CT with iodine quantification in distinguishing between bland and neoplastic portal vein thrombosis in patients with hepatocellular carcinoma. Clin Radiol 71(9):938e1–938e9CrossRef Ascenti G, Sofia C, Mazziotti S, et al. (2016) Dual-energy CT with iodine quantification in distinguishing between bland and neoplastic portal vein thrombosis in patients with hepatocellular carcinoma. Clin Radiol 71(9):938e1–938e9CrossRef
28.
Zurück zum Zitat Qian LJ, Zhu J, Zhuang ZG, et al. (2012) Differentiation of neoplastic from bland macroscopic portal vein thrombi using dual-energy spectral CT imaging: a pilot study. Eur Radiol 22(10):2178–2185CrossRefPubMed Qian LJ, Zhu J, Zhuang ZG, et al. (2012) Differentiation of neoplastic from bland macroscopic portal vein thrombi using dual-energy spectral CT imaging: a pilot study. Eur Radiol 22(10):2178–2185CrossRefPubMed
29.
Zurück zum Zitat Kim JH, Lee JM, Yoon JH, et al. (2016) Portal vein thrombosis in patients with hepatocellular carcinoma: diagnostic accuracy of gadoxetic acid-enhanced MR imaging. Radiology 279(3):773–783CrossRefPubMed Kim JH, Lee JM, Yoon JH, et al. (2016) Portal vein thrombosis in patients with hepatocellular carcinoma: diagnostic accuracy of gadoxetic acid-enhanced MR imaging. Radiology 279(3):773–783CrossRefPubMed
30.
31.
Zurück zum Zitat Sandrasegaran K, Tahir B, Nutakki K, et al. (2013) Usefulness of conventional MRI sequences and diffusion-weighted imaging in differentiating malignant from benign portal vein thrombus in cirrhotic patients. AJR Am J Roentgenol 201(6):1211–1219CrossRefPubMed Sandrasegaran K, Tahir B, Nutakki K, et al. (2013) Usefulness of conventional MRI sequences and diffusion-weighted imaging in differentiating malignant from benign portal vein thrombus in cirrhotic patients. AJR Am J Roentgenol 201(6):1211–1219CrossRefPubMed
32.
Zurück zum Zitat Llovet JM, Zucman-Rossi J, Pikarsky E, et al. (2016) Hepatocellular carcinoma. Nat Rev Dis Primers 2:16018CrossRefPubMed Llovet JM, Zucman-Rossi J, Pikarsky E, et al. (2016) Hepatocellular carcinoma. Nat Rev Dis Primers 2:16018CrossRefPubMed
33.
Zurück zum Zitat Zhang ZM, Lai EC, Zhang C, et al. (2015) The strategies for treating primary hepatocellular carcinoma with portal vein tumor thrombus. Int J Surg 20:8–16CrossRefPubMed Zhang ZM, Lai EC, Zhang C, et al. (2015) The strategies for treating primary hepatocellular carcinoma with portal vein tumor thrombus. Int J Surg 20:8–16CrossRefPubMed
34.
Zurück zum Zitat Shuqun C, Mengchao W, Han C, et al. (2007) Tumor thrombus types influence the prognosis of hepatocellular carcinoma with the tumor thrombi in the portal vein. Hepatogastroenterology 54(74):499–502PubMed Shuqun C, Mengchao W, Han C, et al. (2007) Tumor thrombus types influence the prognosis of hepatocellular carcinoma with the tumor thrombi in the portal vein. Hepatogastroenterology 54(74):499–502PubMed
35.
Zurück zum Zitat Shi J, Lai EC, Li N, et al. (2011) A new classification for hepatocellular carcinoma with portal vein tumor thrombus. J Hepatobiliary Pancreat Sci 18(1):74–80CrossRefPubMed Shi J, Lai EC, Li N, et al. (2011) A new classification for hepatocellular carcinoma with portal vein tumor thrombus. J Hepatobiliary Pancreat Sci 18(1):74–80CrossRefPubMed
36.
Zurück zum Zitat Xu JF, Liu XY, Wang S, Wen HX (2015) Surgical treatment for hepatocellular carcinoma with portal vein tumor thrombus: a novel classification. World J Surg Oncol 13:86CrossRefPubMedPubMedCentral Xu JF, Liu XY, Wang S, Wen HX (2015) Surgical treatment for hepatocellular carcinoma with portal vein tumor thrombus: a novel classification. World J Surg Oncol 13:86CrossRefPubMedPubMedCentral
37.
Zurück zum Zitat Lin DX, Zhang QY, Li X, et al. (2011) An aggressive approach leads to improved survival in hepatocellular carcinoma patients with portal vein tumor thrombus. J Cancer Res Clin Oncol 137(1):139–149CrossRefPubMed Lin DX, Zhang QY, Li X, et al. (2011) An aggressive approach leads to improved survival in hepatocellular carcinoma patients with portal vein tumor thrombus. J Cancer Res Clin Oncol 137(1):139–149CrossRefPubMed
38.
Zurück zum Zitat Peng ZW, Guo RP, Zhang YJ, et al. (2012) Hepatic resection versus transcatheter arterial chemoembolization for the treatment of hepatocellular carcinoma with portal vein tumor thrombus. Cancer 118(19):4725–4736CrossRefPubMed Peng ZW, Guo RP, Zhang YJ, et al. (2012) Hepatic resection versus transcatheter arterial chemoembolization for the treatment of hepatocellular carcinoma with portal vein tumor thrombus. Cancer 118(19):4725–4736CrossRefPubMed
39.
Zurück zum Zitat Choi HJ, Kim DG, Na GH, et al. (2017) The clinical outcomes of patients with portal vein tumor thrombi after living-donor liver transplantation. Liver Transpl 23(8):1023–1031CrossRefPubMed Choi HJ, Kim DG, Na GH, et al. (2017) The clinical outcomes of patients with portal vein tumor thrombi after living-donor liver transplantation. Liver Transpl 23(8):1023–1031CrossRefPubMed
40.
Zurück zum Zitat Kokudo T, Hasegawa K, Matsuyama Y, et al. (2017) Liver resection for hepatocellular carcinoma associated with hepatic vein invasion: a Japanese nationwide survey. Hepatology 66(2):510–517CrossRefPubMed Kokudo T, Hasegawa K, Matsuyama Y, et al. (2017) Liver resection for hepatocellular carcinoma associated with hepatic vein invasion: a Japanese nationwide survey. Hepatology 66(2):510–517CrossRefPubMed
41.
Zurück zum Zitat Zhang YF, Wei W, Guo ZX, et al. (2015) Hepatic resection versus transcatheter arterial chemoembolization for the treatment of hepatocellular carcinoma with hepatic vein tumor thrombus. Jpn J Clin Oncol 45(9):837–843CrossRefPubMed Zhang YF, Wei W, Guo ZX, et al. (2015) Hepatic resection versus transcatheter arterial chemoembolization for the treatment of hepatocellular carcinoma with hepatic vein tumor thrombus. Jpn J Clin Oncol 45(9):837–843CrossRefPubMed
42.
Zurück zum Zitat Giorgio A, Calisti G, Montesarchio L, et al. (2014) Hepatocellular carcinoma invading portal venous system in cirrhosis: long-term results of percutaneous radiofrequency ablation of both the nodule and portal vein tumor thrombus. A case control study. Anticancer Res 34(11):6785–6790PubMed Giorgio A, Calisti G, Montesarchio L, et al. (2014) Hepatocellular carcinoma invading portal venous system in cirrhosis: long-term results of percutaneous radiofrequency ablation of both the nodule and portal vein tumor thrombus. A case control study. Anticancer Res 34(11):6785–6790PubMed
43.
Zurück zum Zitat Zheng JS, Long J, Sun B, et al. (2014) Transcatheter arterial chemoembolization combined with radiofrequency ablation can improve survival of patients with hepatocellular carcinoma with portal vein tumour thrombosis: extending the indication for ablation? Clin Radiol 69(6):e253–e263CrossRefPubMed Zheng JS, Long J, Sun B, et al. (2014) Transcatheter arterial chemoembolization combined with radiofrequency ablation can improve survival of patients with hepatocellular carcinoma with portal vein tumour thrombosis: extending the indication for ablation? Clin Radiol 69(6):e253–e263CrossRefPubMed
44.
Zurück zum Zitat Hirooka M, Koizumi Y, Kisaka Y, et al. (2010) Mass reduction by radiofrequency ablation before hepatic arterial infusion chemotherapy improved prognosis for patients with huge hepatocellular carcinoma and portal vein thrombus. Am J Roentgenol 194(2):W221–W226CrossRef Hirooka M, Koizumi Y, Kisaka Y, et al. (2010) Mass reduction by radiofrequency ablation before hepatic arterial infusion chemotherapy improved prognosis for patients with huge hepatocellular carcinoma and portal vein thrombus. Am J Roentgenol 194(2):W221–W226CrossRef
45.
Zurück zum Zitat Sutter O, Calvo J, N’Kontchou G, et al. (2017) Safety and efficacy of irreversible electroporation for the treatment of hepatocellular carcinoma not amenable to thermal ablation techniques: a retrospective single-center case series. Radiology 284(3):877–886CrossRefPubMed Sutter O, Calvo J, N’Kontchou G, et al. (2017) Safety and efficacy of irreversible electroporation for the treatment of hepatocellular carcinoma not amenable to thermal ablation techniques: a retrospective single-center case series. Radiology 284(3):877–886CrossRefPubMed
46.
Zurück zum Zitat Oliveri RS, Wetterslev J, Gluud C (2011) Transarterial (chemo)embolisation for unresectable hepatocellular carcinoma. Cochrane Database Syst Rev 16(3):CD004787 Oliveri RS, Wetterslev J, Gluud C (2011) Transarterial (chemo)embolisation for unresectable hepatocellular carcinoma. Cochrane Database Syst Rev 16(3):CD004787
47.
Zurück zum Zitat Matsui O, Miyayama S, Sanada J, et al. (2010) Interventional oncology: new options for interstitial treatments and intravascular approaches: superselective TACE using iodized oil for HCC: rationale, technique and outcome. J Hepatobiliary Pancreat Sci 17(4):407–409CrossRefPubMed Matsui O, Miyayama S, Sanada J, et al. (2010) Interventional oncology: new options for interstitial treatments and intravascular approaches: superselective TACE using iodized oil for HCC: rationale, technique and outcome. J Hepatobiliary Pancreat Sci 17(4):407–409CrossRefPubMed
48.
Zurück zum Zitat Silva JP, Berger NG, Tsai S, et al. (2017) Transarterial chemoembolization in hepatocellular carcinoma with portal vein tumor thrombosis: a systematic review and meta-analysis. HPB (Oxford) 19(8):659–666CrossRef Silva JP, Berger NG, Tsai S, et al. (2017) Transarterial chemoembolization in hepatocellular carcinoma with portal vein tumor thrombosis: a systematic review and meta-analysis. HPB (Oxford) 19(8):659–666CrossRef
49.
Zurück zum Zitat Yu JI, Park JW, Park HC, et al. (2016) Clinical impact of combined transarterial chemoembolization and radiotherapy for advanced hepatocellular carcinoma with portal vein tumor thrombosis: an external validation study. Radiother Oncol 118(2):408–415CrossRefPubMed Yu JI, Park JW, Park HC, et al. (2016) Clinical impact of combined transarterial chemoembolization and radiotherapy for advanced hepatocellular carcinoma with portal vein tumor thrombosis: an external validation study. Radiother Oncol 118(2):408–415CrossRefPubMed
50.
Zurück zum Zitat Salem R, Lewandowski RJ, Mulcahy MF, et al. (2010) Radioembolization for hepatocellular carcinoma using Yttrium-90 microspheres: a comprehensive report of long-term outcomes. Gastroenterology 138(1):52–64CrossRefPubMed Salem R, Lewandowski RJ, Mulcahy MF, et al. (2010) Radioembolization for hepatocellular carcinoma using Yttrium-90 microspheres: a comprehensive report of long-term outcomes. Gastroenterology 138(1):52–64CrossRefPubMed
51.
Zurück zum Zitat Tsai AL, Burke CT, Kennedy AS, et al. (2010) Use of yttrium-90 microspheres in patients with advanced hepatocellular carcinoma and portal vein thrombosis. J Vasc Interv Radiol 21(9):1377–1384CrossRefPubMedPubMedCentral Tsai AL, Burke CT, Kennedy AS, et al. (2010) Use of yttrium-90 microspheres in patients with advanced hepatocellular carcinoma and portal vein thrombosis. J Vasc Interv Radiol 21(9):1377–1384CrossRefPubMedPubMedCentral
52.
Zurück zum Zitat Inarrairaegui M, Pardo F, Bilbao JI, et al. (2012) Response to radioembolization with yttrium-90 resin microspheres may allow surgical treatment with curative intent and prolonged survival in previously unresectable hepatocellular carcinoma. Eur J Surg Oncol 38(7):594–601CrossRefPubMed Inarrairaegui M, Pardo F, Bilbao JI, et al. (2012) Response to radioembolization with yttrium-90 resin microspheres may allow surgical treatment with curative intent and prolonged survival in previously unresectable hepatocellular carcinoma. Eur J Surg Oncol 38(7):594–601CrossRefPubMed
53.
Zurück zum Zitat Saxena A, Meteling B, Kapoor J, et al. (2014) Yttrium-90 radioembolization is a safe and effective treatment for unresectable hepatocellular carcinoma: a single centre experience of 45 consecutive patients. Int J Surg 12(12):1403–1408CrossRefPubMed Saxena A, Meteling B, Kapoor J, et al. (2014) Yttrium-90 radioembolization is a safe and effective treatment for unresectable hepatocellular carcinoma: a single centre experience of 45 consecutive patients. Int J Surg 12(12):1403–1408CrossRefPubMed
54.
Zurück zum Zitat Salem R, Gordon AC, Mouli S, Hickey R, Kallini J, Gabr A, et al. (2016) Y90 Radioembolization significantly prolongs time to progression compared with chemoembolization in patients with hepatocellular carcinoma. Gastroenterology 151(6):1155–1163 e2. Salem R, Gordon AC, Mouli S, Hickey R, Kallini J, Gabr A, et al. (2016) Y90 Radioembolization significantly prolongs time to progression compared with chemoembolization in patients with hepatocellular carcinoma. Gastroenterology 151(6):1155–1163 e2.
55.
Zurück zum Zitat Akinwande O, Kim D, Edwards J, et al. (2015) Is radioembolization ((90)Y) better than doxorubicin drug eluting beads (DEBDOX) for hepatocellular carcinoma with portal vein thrombosis? A retrospective analysis. Surg Oncol 24(3):270–275CrossRefPubMed Akinwande O, Kim D, Edwards J, et al. (2015) Is radioembolization ((90)Y) better than doxorubicin drug eluting beads (DEBDOX) for hepatocellular carcinoma with portal vein thrombosis? A retrospective analysis. Surg Oncol 24(3):270–275CrossRefPubMed
56.
Zurück zum Zitat Yu JI, Park HC (2016) Radiotherapy as valid modality for hepatocellular carcinoma with portal vein tumor thrombosis. World J Gastroenterol 22(30):6851–6863CrossRefPubMedPubMedCentral Yu JI, Park HC (2016) Radiotherapy as valid modality for hepatocellular carcinoma with portal vein tumor thrombosis. World J Gastroenterol 22(30):6851–6863CrossRefPubMedPubMedCentral
57.
Zurück zum Zitat Li XL, Guo WX, Hong XD, et al. (2016) Efficacy of the treatment of transarterial chemoembolization combined with radiotherapy for hepatocellular carcinoma with portal vein tumor thrombus: a propensity score analysis. Hepatol Res 46(11):1088–1098CrossRefPubMed Li XL, Guo WX, Hong XD, et al. (2016) Efficacy of the treatment of transarterial chemoembolization combined with radiotherapy for hepatocellular carcinoma with portal vein tumor thrombus: a propensity score analysis. Hepatol Res 46(11):1088–1098CrossRefPubMed
58.
Zurück zum Zitat Huo YR, Eslick GD (2015) Transcatheter arterial chemoembolization plus radiotherapy compared with chemoembolization alone for hepatocellular carcinoma: a systematic review and meta-analysis. JAMA Oncol 1(6):756–765CrossRefPubMed Huo YR, Eslick GD (2015) Transcatheter arterial chemoembolization plus radiotherapy compared with chemoembolization alone for hepatocellular carcinoma: a systematic review and meta-analysis. JAMA Oncol 1(6):756–765CrossRefPubMed
59.
Zurück zum Zitat Zhao Q, Zhu K, Yue J, et al. (2017) Comparison of intra-arterial chemoembolization with and without radiotherapy for advanced hepatocellular carcinoma with portal vein tumor thrombosis: a meta-analysis. Ther Clin Risk Manag 13:21–31CrossRefPubMed Zhao Q, Zhu K, Yue J, et al. (2017) Comparison of intra-arterial chemoembolization with and without radiotherapy for advanced hepatocellular carcinoma with portal vein tumor thrombosis: a meta-analysis. Ther Clin Risk Manag 13:21–31CrossRefPubMed
60.
Zurück zum Zitat Bujold A, Massey CA, Kim JJ, et al. (2013) Sequential phase I and II trials of stereotactic body radiotherapy for locally advanced hepatocellular carcinoma. J Clin Oncol 31(13):1631–1639CrossRefPubMed Bujold A, Massey CA, Kim JJ, et al. (2013) Sequential phase I and II trials of stereotactic body radiotherapy for locally advanced hepatocellular carcinoma. J Clin Oncol 31(13):1631–1639CrossRefPubMed
61.
Zurück zum Zitat Xi M, Zhang L, Zhao L, et al. (2013) Effectiveness of stereotactic body radiotherapy for hepatocellular carcinoma with portal vein and/or inferior vena cava tumor thrombosis. PLoS ONE 8(5):e63864CrossRefPubMedPubMedCentral Xi M, Zhang L, Zhao L, et al. (2013) Effectiveness of stereotactic body radiotherapy for hepatocellular carcinoma with portal vein and/or inferior vena cava tumor thrombosis. PLoS ONE 8(5):e63864CrossRefPubMedPubMedCentral
62.
Zurück zum Zitat Matsuo Y, Yoshida K, Nishimura H, et al. (2016) Efficacy of stereotactic body radiotherapy for hepatocellular carcinoma with portal vein tumor thrombosis/inferior vena cava tumor thrombosis: evaluation by comparison with conventional three-dimensional conformal radiotherapy. J Radiat Res 57(5):512–523CrossRefPubMedPubMedCentral Matsuo Y, Yoshida K, Nishimura H, et al. (2016) Efficacy of stereotactic body radiotherapy for hepatocellular carcinoma with portal vein tumor thrombosis/inferior vena cava tumor thrombosis: evaluation by comparison with conventional three-dimensional conformal radiotherapy. J Radiat Res 57(5):512–523CrossRefPubMedPubMedCentral
63.
Zurück zum Zitat Hata M, Tokuuye K, Sugahara S, et al. (2005) Proton beam therapy for hepatocellular carcinoma with portal vein tumor thrombus. Cancer 104(4):794–801CrossRefPubMed Hata M, Tokuuye K, Sugahara S, et al. (2005) Proton beam therapy for hepatocellular carcinoma with portal vein tumor thrombus. Cancer 104(4):794–801CrossRefPubMed
64.
Zurück zum Zitat Sugahara S, Nakayama H, Fukuda K, et al. (2009) Proton-beam therapy for hepatocellular carcinoma associated with portal vein tumor thrombosis. Strahlenther Onkol 185(12):782–788CrossRefPubMed Sugahara S, Nakayama H, Fukuda K, et al. (2009) Proton-beam therapy for hepatocellular carcinoma associated with portal vein tumor thrombosis. Strahlenther Onkol 185(12):782–788CrossRefPubMed
65.
Zurück zum Zitat Kawashima M, Kohno R, Nakachi K, et al. (2011) Dose-volume histogram analysis of the safety of proton beam therapy for unresectable hepatocellular carcinoma. Int J Radiat Oncol Biol Phys 79(5):1479–1486CrossRefPubMed Kawashima M, Kohno R, Nakachi K, et al. (2011) Dose-volume histogram analysis of the safety of proton beam therapy for unresectable hepatocellular carcinoma. Int J Radiat Oncol Biol Phys 79(5):1479–1486CrossRefPubMed
66.
Zurück zum Zitat Lee SU, Park JW, Kim TH, et al. (2014) Effectiveness and safety of proton beam therapy for advanced hepatocellular carcinoma with portal vein tumor thrombosis. Strahlenther Onkol 190(9):806–814CrossRefPubMed Lee SU, Park JW, Kim TH, et al. (2014) Effectiveness and safety of proton beam therapy for advanced hepatocellular carcinoma with portal vein tumor thrombosis. Strahlenther Onkol 190(9):806–814CrossRefPubMed
67.
Zurück zum Zitat Llovet JM, Ricci S, Mazzaferro V, et al. (2008) Sorafenib in advanced hepatocellular carcinoma. N Engl J Med 359(4):378–390CrossRefPubMed Llovet JM, Ricci S, Mazzaferro V, et al. (2008) Sorafenib in advanced hepatocellular carcinoma. N Engl J Med 359(4):378–390CrossRefPubMed
68.
Zurück zum Zitat Bruix J, Qin S, Merle P, et al. (2017) Regorafenib for patients with hepatocellular carcinoma who progressed on sorafenib treatment (RESORCE): a randomised, double-blind, placebo-controlled, phase 3 trial. Lancet 389(10064):56–66CrossRefPubMed Bruix J, Qin S, Merle P, et al. (2017) Regorafenib for patients with hepatocellular carcinoma who progressed on sorafenib treatment (RESORCE): a randomised, double-blind, placebo-controlled, phase 3 trial. Lancet 389(10064):56–66CrossRefPubMed
69.
70.
Zurück zum Zitat Bridgewater J, Galle PR, Khan SA, et al. (2014) Guidelines for the diagnosis and management of intrahepatic cholangiocarcinoma. J Hepatol 60(6):1268–1289CrossRefPubMed Bridgewater J, Galle PR, Khan SA, et al. (2014) Guidelines for the diagnosis and management of intrahepatic cholangiocarcinoma. J Hepatol 60(6):1268–1289CrossRefPubMed
71.
Zurück zum Zitat Bach AM, Hann LE, Brown KT, et al. (1996) Portal vein evaluation with US: comparison to angiography combined with CT arterial portography. Radiology 201(1):149–154CrossRefPubMed Bach AM, Hann LE, Brown KT, et al. (1996) Portal vein evaluation with US: comparison to angiography combined with CT arterial portography. Radiology 201(1):149–154CrossRefPubMed
72.
Zurück zum Zitat Hann LE, Schwartz LH, Panicek DM, et al. (1998) Tumor involvement in hepatic veins: comparison of MR imaging and US for preoperative assessment. Radiology 206(3):651–656CrossRefPubMed Hann LE, Schwartz LH, Panicek DM, et al. (1998) Tumor involvement in hepatic veins: comparison of MR imaging and US for preoperative assessment. Radiology 206(3):651–656CrossRefPubMed
73.
Zurück zum Zitat van Hazel GA, Heinemann V, Sharma NK, et al. (2016) SIRFLOX: randomized phase III trial comparing first-line mFOLFOX6 (Plus or Minus Bevacizumab) versus mFOLFOX6 (Plus or Minus Bevacizumab) plus selective internal radiation therapy in patients with metastatic colorectal cancer. J Clin Oncol 34(15):1723–1731CrossRefPubMed van Hazel GA, Heinemann V, Sharma NK, et al. (2016) SIRFLOX: randomized phase III trial comparing first-line mFOLFOX6 (Plus or Minus Bevacizumab) versus mFOLFOX6 (Plus or Minus Bevacizumab) plus selective internal radiation therapy in patients with metastatic colorectal cancer. J Clin Oncol 34(15):1723–1731CrossRefPubMed
Metadaten
Titel
Venous invasion by hepatic tumors: imaging appearance and implications for management
verfasst von
Scott M. Thompson
Michael L. Wells
James C. Andrews
Eric C. Ehman
Christine O. Menias
Christopher L. Hallemeier
Lewis R. Roberts
Sudhakar K. Venkatesh
Publikationsdatum
19.09.2017
Verlag
Springer US
Erschienen in
Abdominal Radiology / Ausgabe 8/2018
Print ISSN: 2366-004X
Elektronische ISSN: 2366-0058
DOI
https://doi.org/10.1007/s00261-017-1298-x

Weitere Artikel der Ausgabe 8/2018

Abdominal Radiology 8/2018 Zur Ausgabe

Classics in Abdominal Radiology

Daughter cyst sign in ovarian cysts

Update Radiologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.